First-In-Human Study of EOS884448 in Participants with Advanced Cancers.

NCT04335253 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: EOS884448

Sponsor

iTeos Therapeutics

Collaborators

[object Object]